Počet záznamov: 1
Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial
- Safety and immunogenicity of the tau vaccine AADvac1 in patients with Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 1 trial / Novak P. ... [et al.] . The Lancet. Neurology . - Vol. 16, no. 2 (2017), s. 123–134 [Dokument nie je vo fonde knižnice]
článok
Počet záznamov: 1